首页> 美国卫生研究院文献>Oncotarget >A functional variant in HOXA11-AS a novel long non-coding RNA inhibits the oncogenic phenotype of epithelial ovarian cancer
【2h】

A functional variant in HOXA11-AS a novel long non-coding RNA inhibits the oncogenic phenotype of epithelial ovarian cancer

机译:HOXA11-AS中的功能性变异体(一种新型的长非编码RNA)可抑制上皮性卵巢癌的致癌表型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The homeobox A (HOXA) region of protein-coding genes impacts female reproductive system embryogenesis and ovarian carcinogenesis. The 5-prime end of HOXA includes three long non-coding RNAs (lncRNAs) (HOXA10-AS, HOXA11-AS, and HOTTIP) that are underexplored in epithelial ovarian cancer (EOC). We evaluated whether common genetic variants in these lncRNAs are associated with EOC risk and/or have functional roles in EOC development. Using genome-wide association study data from 1,201 serous EOC cases and 2,009 controls, an exonic variant within HOXA11-AS, rs17427875 (A>T), was marginally associated with reduced serous EOC risk (OR = 0.88 (95% CI: 0.78-1.01, p = 0.06). Functional studies of ectopic expression of HOXA11-AS minor allele T in EOC cells showed decreased survival, proliferation, migration, and invasion compared to common allele A expression. Additionally, stable expression of HOXA11-AS minor allele T reduced primary tumor growth in mouse xenograft models to a greater extent than common allele A. Furthermore, HOXA11-AS expression levels were significantly lower in human EOC tumors than normal ovarian tissues (p < 0.05), suggesting that HOXA11-AS has a tumor suppressor function in EOC which may be enhanced by the T allele. These findings demonstrate for the first time a role for HOXA11-AS in EOC with effects that could be modified by germline variants.
机译:蛋白质编码基因的同源盒A(HOXA)区影响女性生殖系统的胚胎发生和卵巢癌发生。 HOXA的5个引物末端包括三个在上皮性卵巢癌(EOC)中未开发的长非编码RNA(lncRNA)(HOXA10-AS,HOXA11-AS和HOTTIP)。我们评估了这些lncRNA中常见的遗传变异是否与EOC风险相关和/或在EOC发育中具有功能性作用。使用来自1,201例浆液性EOC病例和2,009例对照的全基因组关联研究数据,HOXA11-AS中的外显子变体rs17427875(A> T)与浆液性EOC风险降低相关(OR = 0.88(95%CI:0.78- 1.01,p = 0.06)。EOC细胞中HOXA11-AS次要等位基因T异位表达的功能研究表明,与普通等位基因A表达相比,其存活,增殖,迁移和侵袭减少,此外,HOXA11-AS次要等位基因T稳定表达与普通等位基因A相比,小鼠异种移植模型中的原发肿瘤生长降低程度更大。此外,人EOC肿瘤中HOXA11-AS表达水平显着低于正常卵巢组织(p <0.05),这表明HOXA11-AS具有抑癌作用这些发现首次证明了HOXA11-AS在EOC中的作用,其作用可以被种系变体修饰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号